Larimar Therapeutics, Inc. - Common Stock (NQ:LRMR)
3.880
+0.130
(+3.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 25, 2025
Add to My Watchlist
All News about Larimar Therapeutics, Inc. - Common Stock![]() ![]() ![]() ![]()
After One Year Of Regulatory Hold, Larimar's Ataxia Candidate Sees Some Hope
September 14, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
October 19, 2022
Via Benzinga
![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2022
September 19, 2022
Via Benzinga
![]()
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|